2024 Q3 Form 10-Q Financial Statement

#000121390024068973 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q4
Revenue $5.536M $4.492M $24.59M
YoY Change -86.91%
Cost Of Revenue $8.693M $5.384M $18.35M
YoY Change -74.0% -61.06%
Gross Profit -$3.157M -$892.0K $6.236M
YoY Change -135.62% -131.3%
Gross Profit Margin -57.03% -19.86% 25.36%
Selling, General & Admin $19.54M $7.297M $2.214M
YoY Change -42.67% 224.72%
% of Gross Profit 35.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $329.0K -$1.406M
YoY Change
% of Gross Profit -22.55%
Operating Expenses $26.81M $8.602M $17.31M
YoY Change -21.34% 469.67% 570.98%
Operating Profit -$29.97M -$9.494M -$11.08M
YoY Change 18.81% 528.21%
Interest Expense $50.00K $442.0K $1.902M
YoY Change -100.72% -68.65% -32.1%
% of Operating Profit
Other Income/Expense, Net -$47.99M -$4.383M -$38.00M
YoY Change -594.67% 283.06% 2973.88%
Pretax Income -$77.96M -$13.88M -$50.97M
YoY Change 246.87% 421.69% 6753.46%
Income Tax $10.00K -$1.000K
% Of Pretax Income
Net Earnings -$77.96M -$15.89M -$206.9M
YoY Change 122.58% 498.53% 27715.32%
Net Earnings / Revenue -1408.2% -353.83% -841.33%
Basic Earnings Per Share -$1.03 -$0.26 -$5.20
Diluted Earnings Per Share -$1.03 -$0.26 -$5.19
COMMON SHARES
Basic Shares Outstanding 63.61M shares 49.10M shares 39.82M shares
Diluted Shares Outstanding 75.35M shares 61.11M shares 39.83M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $51.84M $1.661M
YoY Change 2177.84%
Cash & Equivalents $79.50M $1.839M $1.661M
Short-Term Investments $50.00M
Other Short-Term Assets $7.140M $9.947M
YoY Change 8142.46%
Inventory $607.0K $2.033M $12.50M
Prepaid Expenses
Receivables $8.482M $13.00M $26.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $102.5M $24.02M $50.11M
YoY Change 105.74% 738595.79% 25785.33%
LONG-TERM ASSETS
Property, Plant & Equipment $590.0K $4.456M $4.185M
YoY Change -89.54% 20.4%
Goodwill
YoY Change
Intangibles $0.00
YoY Change -100.0%
Long-Term Investments $3.500M
YoY Change -99.0%
Other Assets $154.0K $198.0K $198.0K
YoY Change -98.31%
Total Long-Term Assets $5.453M $9.377M $21.91M
YoY Change -96.89% -92.08% -93.74%
TOTAL ASSETS
Total Short-Term Assets $102.5M $24.02M $50.11M
Total Long-Term Assets $5.453M $9.377M $21.91M
Total Assets $107.9M $33.39M $72.02M
YoY Change -52.05% -71.79% -79.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.627M $11.00M $14.57M
YoY Change -69.3% 57.07% 199.92%
Accrued Expenses $23.23M $19.28M
YoY Change
Deferred Revenue $1.092M $1.248M $2.423M
YoY Change
Short-Term Debt $30.38M $27.93M
YoY Change 767.91% 3271.23%
Long-Term Debt Due $37.15M $29.19M
YoY Change
Total Short-Term Liabilities $41.71M $113.3M $107.4M
YoY Change -44.03% 979.85% 1788.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.416M $15.42M
YoY Change -63.27% 157.16%
Total Long-Term Liabilities $3.416M $15.42M
YoY Change -63.27% 157.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $41.71M $113.3M $107.4M
Total Long-Term Liabilities $3.416M $15.42M
Total Liabilities $250.6M $125.4M $122.8M
YoY Change 64.08% 533.41% 951.04%
SHAREHOLDERS EQUITY
Retained Earnings -$458.4M -$380.4M -$327.3M
YoY Change 1798.83% 1764.99%
Common Stock $315.5M $288.3M $7.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$142.7M -$91.97M -$50.78M
YoY Change
Total Liabilities & Shareholders Equity $107.9M $33.39M $72.02M
YoY Change -52.05% -71.79% -79.43%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q4
OPERATING ACTIVITIES
Net Income -$77.96M -$15.89M -$206.9M
YoY Change 122.58% 498.53% 27715.32%
Depreciation, Depletion And Amortization $329.0K -$1.406M
YoY Change
Cash From Operating Activities -$2.691M -$20.14M
YoY Change 691.47% 6162.48%
INVESTING ACTIVITIES
Capital Expenditures $347.0K $529.0K
YoY Change 1056.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 $8.145M
YoY Change -100.0%
Cash From Investing Activities -$347.0K -$530.0K
YoY Change -13.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.034M 19.77M
YoY Change 333.43% 8686.22%
NET CHANGE
Cash From Operating Activities -2.691M -20.14M
Cash From Investing Activities -347.0K -530.0K
Cash From Financing Activities 3.034M 19.77M
Net Change In Cash -4.000K -903.0K
YoY Change -90.0% 834.49%
FREE CASH FLOW
Cash From Operating Activities -$2.691M -$20.14M
Capital Expenditures $347.0K $529.0K
Free Cash Flow -$3.038M -$20.67M
YoY Change 721.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.81
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.17
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.24
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.43
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40117
dei Entity Registrant Name
EntityRegistrantName
COMPLETE SOLARIA, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
93-2279786
dei Entity Address Address Line1
EntityAddressAddressLine1
45700 Northport Loop East
dei Entity Address City Or Town
EntityAddressCityOrTown
Fremont
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94538
dei City Area Code
CityAreaCode
(510)
dei Local Phone Number
LocalPhoneNumber
270-2507
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
63613798 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1839000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2593000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13003000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26281000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
2033000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3058000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7140000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5817000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
24015000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
37749000 usd
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3838000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3823000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4456000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4317000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
885000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1235000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
198000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
198000 usd
CY2024Q2 us-gaap Assets
Assets
33392000 usd
CY2023Q4 us-gaap Assets
Assets
47322000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10995000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13122000 usd
CY2024Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
25832000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
27870000 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
30377000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
28657000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1248000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2423000 usd
CY2024Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
37152000 usd
CY2023Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
33280000 usd
CY2024Q2 cslr Safe Agreements Current
SAFEAgreementsCurrent
1000000 usd
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
6653000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3831000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
113257000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
109183000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3416000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3416000 usd
CY2024Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
7192000 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
9817000 usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1055000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1055000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
445000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
664000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
125365000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
124135000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63044287 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63044287 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49065361 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49065361 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
13000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
7000 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
288259000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
165000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
143000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-380410000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-354928000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-91973000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-76813000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33392000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47322000 usd
CY2024Q2 us-gaap Revenues
Revenues
4492000 usd
CY2023Q3 us-gaap Revenues
Revenues
25620000 usd
us-gaap Revenues
Revenues
14532000 usd
us-gaap Revenues
Revenues
42297000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
5384000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
19607000 usd
us-gaap Cost Of Revenue
CostOfRevenue
13141000 usd
us-gaap Cost Of Revenue
CostOfRevenue
33434000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
-892000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
6013000 usd
us-gaap Gross Profit
GrossProfit
1391000 usd
us-gaap Gross Profit
GrossProfit
8863000 usd
CY2024Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
1305000 usd
CY2023Q3 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
8789000 usd
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
4421000 usd
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
14466000 usd
CY2024Q2 us-gaap Marketing Expense
MarketingExpense
1051000 usd
CY2023Q3 us-gaap Marketing Expense
MarketingExpense
2319000 usd
us-gaap Marketing Expense
MarketingExpense
2669000 usd
us-gaap Marketing Expense
MarketingExpense
3002000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6246000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7707000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11339000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16620000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
8602000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
18815000 usd
us-gaap Operating Expenses
OperatingExpenses
18429000 usd
us-gaap Operating Expenses
OperatingExpenses
34088000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9494000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12802000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-17038000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-25225000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2324000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3357000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5892000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
6968000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
9000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
16000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
17000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2069000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9384000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-550000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9701000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4383000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6036000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6426000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2750000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13877000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6766000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23464000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22475000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-13887000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6766000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-23475000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-22475000 usd
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2007000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-4744000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2007000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-12549000 usd
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2007000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-4744000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2007000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-12549000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-15894000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-11510000 usd
us-gaap Net Income Loss
NetIncomeLoss
-25482000 usd
us-gaap Net Income Loss
NetIncomeLoss
-35024000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
67000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15827000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11497000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25504000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35010000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.23
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.24
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.43
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.81
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.17
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.46
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.27
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61111005 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27671302 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54941543 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27638062 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-85079000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1229000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1420000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
6250000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-15894000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
67000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-91973000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
82845000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1020000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
13000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-11510000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
72370000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-76813000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
60000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2570000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1420000 usd
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
6250000 usd
us-gaap Net Income Loss
NetIncomeLoss
-25482000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
22000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-91973000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
105281000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
57000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2042000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
14000 usd
us-gaap Net Income Loss
NetIncomeLoss
-35024000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
72370000 usd
us-gaap Net Income Loss
NetIncomeLoss
-25482000 usd
us-gaap Net Income Loss
NetIncomeLoss
-35024000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2007000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-12549000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-23475000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-22475000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2570000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
742000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
2020000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
3669000 usd
cslr Non Cash Lease Expense
NonCashLeaseExpense
349000 usd
cslr Non Cash Lease Expense
NonCashLeaseExpense
484000 usd
cslr Loss On Conversion Of Safe Agreements To Shares Of Common Stock
LossOnConversionOfSAFEAgreementsToSharesOfCommonStock
1250000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
1639000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
686000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
403000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
900000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4698000 usd
cslr Change In Reserve For Excess And Obsolete Inventory
ChangeInReserveForExcessAndObsoleteInventory
-1228000 usd
cslr Change In Reserve For Excess And Obsolete Inventory
ChangeInReserveForExcessAndObsoleteInventory
1366000 usd
cslr Change In Fair Value Of Forward Purchase Agreement Liabilitie
ChangeInFairValueOfForwardPurchaseAgreementLiabilitie
2822000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2625000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9416000 usd
cslr Accretion Of Longterm Debt In Cs Solis
AccretionOfLongtermDebtInCSSolis
3872000 usd
cslr Accretion Of Longterm Debt In Cs Solis
AccretionOfLongtermDebtInCSSolis
1508000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12378000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8033000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2311000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1856000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1422000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2687000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4030000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2125000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4785000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6051000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3368000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-332000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-240000 usd
cslr Increase Decrease In Warranty Provision Noncurrent
IncreaseDecreaseInWarrantyProvisionNoncurrent
20000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1176000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-89000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7637000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-27783000 usd
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
963000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7637000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26820000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30000 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
883000 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
975000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-883000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1004000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
14102000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
300000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
9603000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
21250000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
60000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
57000 usd
cslr Investor Financing Deposit Related Party
InvestorFinancingDepositRelatedParty
2000000 usd
cslr Proceeds From Issuance Of Safe Agreements
ProceedsFromIssuanceOfSAFEAgreements
6000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7760000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25806000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-739000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2004000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6416000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8316000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5677000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6312000 usd
us-gaap Interest Paid Net
InterestPaidNet
1789000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
10000 usd
cslr Conversion Of Safe Agreements To Equity
ConversionOfSAFEAgreementsToEquity
5000000 usd
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2010-02-22
cslr Purchase Price Per Share
PurchasePricePerShare
10
CY2023Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
23256504 shares
CY2024Q2 us-gaap Debt Current
DebtCurrent
67500000 usd
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1800000 usd
CY2024Q2 us-gaap Marketable Securities
MarketableSecurities
50000000 usd
CY2024Q2 us-gaap Marketable Securities
MarketableSecurities
50000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"></td> <td style="width: 24px"><span style="font-size: 10pt"><b><i>(b)</i></b></span></td> <td><span style="font-size: 10pt"><b><i>Use of Estimates</i></b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">The allocation of the transaction price to identified performance obligations;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Fair value of warrant liabilities;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">The fair value of the forward purchase agreements; and</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">The reserve methodology for inventory obsolescence;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">The reserve methodology for product warranty;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">The reserve methodology for the allowance for credit losses;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">The measurement of stock-based compensation.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis. The Company has assessed the impact and management is not aware of any specific events or circumstances that required an update to the Company’s estimates and assumptions or materially affected the carrying value of the Company’s assets or liabilities as of the date of issuance of this report. These estimates may change as new events occur and additional information is obtained.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"></td> <td style="width: 24px"><span style="font-size: 10pt"><b><i>(d)</i></b></span></td> <td><span style="font-size: 10pt"><b><i>Concentration of Risks </i></b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company’s cash and cash equivalents are on deposit with major financial institutions. Such deposits may be in excess of insured limits from time to time. The Company believes that the financial institutions that hold the Company’s cash are financially sound, and accordingly, minimum credit risk exists with respect to these balances. The Company has not experienced any losses due to institutional failure or bankruptcy. The Company’s customers consist primarily of residential homeowners. The Company performs credit evaluations of its customers and generally does not require collateral for sales on credit. Many residential customers finance the transaction through third-party financing entities from whom the Company collects the receivable. The Company reviews accounts receivable balances to determine if any receivables will potentially be uncollectible and includes any amounts that are determined to be uncollectible in the allowance for credit losses. As of June 30, 2024, two entities had an outstanding balance that represented 18% and <span style="-sec-ix-hidden: hidden-fact-137"><span style="-sec-ix-hidden: hidden-fact-138">16</span></span>% of the total accounts receivable balance. As of December 31, 2023, two entities had an outstanding balance that represented 38% and 16% of the total accounts receivable balance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of customers</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify">No customers represented more than 10% of gross revenues from continuing operations for the thirteen and twenty-six weeks ended June 30, 2024 and July 2, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of suppliers</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the thirteen-weeks ended June 30, 2024, three suppliers represented 53%, 17% and 14%, of the Company’s inventory purchases. For the twenty-six weeks ended June 30, 2024, one supplier represented 83% of the Company’s inventory purchases. For the thirteen-weeks and twenty-six weeks ended July 2, 2023, one supplier represented 91% and 87% of the Company’s inventory purchases, respectively.</p>
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3800000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3800000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1839000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2593000 usd
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3838000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3823000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5677000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6416000 usd
CY2024Q2 us-gaap Revenues
Revenues
4492000 usd
CY2023Q3 us-gaap Revenues
Revenues
25620000 usd
us-gaap Revenues
Revenues
14532000 usd
us-gaap Revenues
Revenues
42297000 usd
CY2024Q2 us-gaap Amount Of Deferred Costs Related To Long Term Contracts
AmountOfDeferredCostsRelatedToLongTermContracts
1100000 usd
CY2023Q4 us-gaap Amount Of Deferred Costs Related To Long Term Contracts
AmountOfDeferredCostsRelatedToLongTermContracts
1200000 usd
CY2024Q2 cslr Deferred Commission
DeferredCommission
6200000 usd
CY2023Q4 cslr Deferred Commission
DeferredCommission
4200000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1900000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2800000 usd
cslr Direct Offering Costs
DirectOfferingCosts
5700000 usd
CY2024Q2 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
14845000 usd
CY2023Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
14959000 usd
cslr Net Cash Proceeds
NetCashProceeds
19700000 usd
us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
10100000 usd
CY2024Q2 us-gaap Temporary Equity Share Subscriptions
TemporaryEquityShareSubscriptions
31041243 shares
CY2024Q2 cslr Shares From The Mergers And Pipe Financing
SharesFromTheMergersAndPIPEFinancing
19796221 shares
CY2024Q2 cslr Legacy In Shares
LegacyInShares
20034257 shares
CY2024Q2 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
5460075 shares
CY2024Q2 cslr Shares Of Complete Solaria Common Stock Immediately After Mergers
SharesOfCompleteSolariaCommonStockImmediatelyAfterMergers
45290553 shares
CY2023Q4 us-gaap Cash
Cash
5400000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 cslr Reset Price Per Share
ResetPricePerShare
10.56
CY2024Q2 cslr Price On Floor
PriceOnFloor
5
CY2023Q4 cslr Reset Floor Price
ResetFloorPrice
3
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
10000000 usd
CY2024Q2 cslr Deferred Commissions Current
DeferredCommissionsCurrent
6202000 usd
CY2023Q4 cslr Deferred Commissions Current
DeferredCommissionsCurrent
4185000 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
616000 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
938000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1016000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7140000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5817000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8753000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7928000 usd
CY2024Q2 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
4297000 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
3611000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4456000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4317000 usd
CY2024Q2 us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
300000 usd
CY2023Q3 us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
200000 usd
us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
700000 usd
us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
400000 usd
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4071000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3969000 usd
CY2024Q2 cslr Accrued Customer Deposits
AccruedCustomerDeposits
243000 usd
CY2023Q4 cslr Accrued Customer Deposits
AccruedCustomerDeposits
544000 usd
CY2023Q4 cslr Accrued Uninvoiced Contract Costs
AccruedUninvoicedContractCosts
671000 usd
CY2024Q2 cslr Accrued Term Loan And Revolving Loan Amendment And Final Payment Fees
AccruedTermLoanAndRevolvingLoanAmendmentAndFinalPaymentFees
2400000 usd
CY2023Q4 cslr Accrued Term Loan And Revolving Loan Amendment And Final Payment Fees
AccruedTermLoanAndRevolvingLoanAmendmentAndFinalPaymentFees
2400000 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7700000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7700000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
931000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
931000 usd
CY2024Q2 cslr Accrued Rebate And Credits
AccruedRebateAndCredits
28000 usd
CY2023Q4 cslr Accrued Rebate And Credits
AccruedRebateAndCredits
677000 usd
CY2024Q2 cslr Accured Operating Lease Liabilities Current
AccuredOperatingLeaseLiabilitiesCurrent
475000 usd
CY2023Q4 cslr Accured Operating Lease Liabilities Current
AccuredOperatingLeaseLiabilitiesCurrent
607000 usd
CY2024Q2 cslr Accrued Warranty Current
AccruedWarrantyCurrent
1425000 usd
CY2023Q4 cslr Accrued Warranty Current
AccruedWarrantyCurrent
1433000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8559000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8938000 usd
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
25832000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
27870000 usd
CY2024Q2 cslr Loss On Conversion Of Safe Agreements To Shares Of Common Stock
LossOnConversionOfSAFEAgreementsToSharesOfCommonStock
1250000 usd
cslr Loss On Conversion Of Safe Agreements To Shares Of Common Stock
LossOnConversionOfSAFEAgreementsToSharesOfCommonStock
1250000 usd
CY2024Q2 cslr Loss On Discontinued Solaria Business And Other Net
LossOnDiscontinuedSolariaBusinessAndOtherNet
-266000 usd
CY2023Q3 cslr Loss On Discontinued Solaria Business And Other Net
LossOnDiscontinuedSolariaBusinessAndOtherNet
177000 usd
cslr Loss On Discontinued Solaria Business And Other Net
LossOnDiscontinuedSolariaBusinessAndOtherNet
-414000 usd
cslr Loss On Discontinued Solaria Business And Other Net
LossOnDiscontinuedSolariaBusinessAndOtherNet
285000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2069000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9384000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-550000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9701000 usd
CY2024Q2 us-gaap Interest Income Other
InterestIncomeOther
2300000 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
0 usd
us-gaap Interest Income Other
InterestIncomeOther
2400000 usd
us-gaap Interest Income Other
InterestIncomeOther
0 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
33637266 shares
CY2024Q2 cslr Stock Issued During Employee Stock Purchase Plan
StockIssuedDuringEmployeeStockPurchasePlan
2628996 shares
CY2024Q2 cslr Stock Options And Restricted Stock Units Issued And Outstanding
StockOptionsAndRestrictedStockUnitsIssuedAndOutstanding
14498758 shares
CY2024Q2 cslr Stock Options And Restricted Stock Units Authorized For Future Issuance
StockOptionsAndRestrictedStockUnitsAuthorizedForFutureIssuance
729211 shares
CY2024Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
51494231 shares
CY2024Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
7192000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
11127000 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2190604 shares
CY2023Q3 cslr Percentage Of Common Stock Shares Issued
PercentageOfCommonStockSharesIssued
0.02795 pure
CY2023Q3 cslr Percentage Of Common Stock Shares Outstanding
PercentageOfCommonStockSharesOutstanding
0.02795 pure
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
9500000 usd
CY2024Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8625000 shares
CY2023Q3 cslr Warrant Expire Period
WarrantExpirePeriod
July 2028
cslr Exercise Warrants Shares
ExerciseWarrantsShares
2000000 shares
CY2024Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
30377000 usd
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
28657000 usd
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
37152000 usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
33280000 usd
CY2024Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
67529000 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
61937000 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
67529000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
61937000 usd
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1000000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y2M23D
cslr Percentage Of Fair Market Values Of Stock
PercentageOfFairMarketValuesOfStock
0.85 pure
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4849000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3981000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
361000 usd
CY2023 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2968000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
370000 usd
CY2023 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2100000 usd
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4840000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4849000 usd
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1424000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1433000 usd
CY2024Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3416000 usd
CY2023Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3416000 usd
CY2023Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
7900000 usd
CY2023Q1 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
220000000 usd
CY2021Q3 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
6900000 usd
CY2024Q1 cslr Subsidiaries Indemnity Obligations
SubsidiariesIndemnityObligations
6900000 usd
us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
6900000 usd
CY2023 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
6900000 usd
CY2023Q3 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
6000000 usd
CY2024Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3800000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
3800000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-13887000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6766000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-23475000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-22475000 usd
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2007000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-4744000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2007000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-12549000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-15894000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-11510000 usd
us-gaap Net Income Loss
NetIncomeLoss
-25482000 usd
us-gaap Net Income Loss
NetIncomeLoss
-35024000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61111005 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27671302 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54941543 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27638062 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.23
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.24
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.43
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.81
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.17
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.46
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.27
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37465217 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7851782 shares
CY2023Q2 cslr Prefunded Pipe Proceeds Received
PrefundedPIPEProceedsReceived
3500000 usd
CY2023Q3 cslr Prefunded Pipe Proceeds Received
PrefundedPIPEProceedsReceived
12100000 usd
CY2024Q2 cslr Forward Purchase Agreement Liability
ForwardPurchaseAgreementLiability
5600000 usd
CY2023Q4 cslr Forward Purchase Agreement Liability
ForwardPurchaseAgreementLiability
3200000 usd
CY2024Q2 us-gaap Other Income
OtherIncome
2400000 usd
us-gaap Other Expenses
OtherExpenses
2400000 usd
CY2023 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
200000 usd
CY2023Q4 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
5000000 usd
CY2024Q1 cslr Proceeds From Safe
ProceedsFromSAFE
6000000 usd
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
13888889 shares
cslr Recognized Loss
RecognizedLoss
1300000 usd
CY2024Q2 us-gaap Security Deposit
SecurityDeposit
2000000 usd
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 cslr Safe Agreements Current
SAFEAgreementsCurrent
usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
277965000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.23
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.46
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.27
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27638062 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27671302 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54941543 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61111005 shares
cslr Loss On Conversion Of Safe Agreements To Shares Of Common Stock
LossOnConversionOfSAFEAgreementsToSharesOfCommonStock
usd
us-gaap Other Noncash Expense
OtherNoncashExpense
usd
cslr Change In Fair Value Of Forward Purchase Agreement Liabilitie
ChangeInFairValueOfForwardPurchaseAgreementLiabilitie
usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
usd
cslr Increase Decrease In Warranty Provision Noncurrent
IncreaseDecreaseInWarrantyProvisionNoncurrent
usd
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
cslr Investor Financing Deposit Related Party
InvestorFinancingDepositRelatedParty
usd
cslr Proceeds From Issuance Of Safe Agreements
ProceedsFromIssuanceOfSAFEAgreements
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
cslr Conversion Of Safe Agreements To Equity
ConversionOfSAFEAgreementsToEquity
usd
CY2024Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
usd
CY2024Q2 cslr Accrued Uninvoiced Contract Costs
AccruedUninvoicedContractCosts
usd
CY2023Q3 cslr Loss On Conversion Of Safe Agreements To Shares Of Common Stock
LossOnConversionOfSAFEAgreementsToSharesOfCommonStock
usd
cslr Loss On Conversion Of Safe Agreements To Shares Of Common Stock
LossOnConversionOfSAFEAgreementsToSharesOfCommonStock
usd
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
CY2024Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27638062 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27671302 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54941543 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61111005 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.23
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.24
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.43
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.81
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.17
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.46
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.27
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001838987

Files In Submission

Name View Source Status
0001213900-24-068973-index-headers.html Edgar Link pending
0001213900-24-068973-index.html Edgar Link pending
0001213900-24-068973.txt Edgar Link pending
0001213900-24-068973-xbrl.zip Edgar Link pending
cslr-20240630.xsd Edgar Link pending
ea0210556-10q_complete.htm Edgar Link pending
cslr-20240630_cal.xml Edgar Link unprocessable
cslr-20240630_lab.xml Edgar Link unprocessable
cslr-20240630_pre.xml Edgar Link unprocessable
ea0210556-10q_complete_htm.xml Edgar Link completed
ea021055601ex10-2_complete.htm Edgar Link pending
ea021055601ex10-7_complete.htm Edgar Link pending
ea021055601ex10-8_complete.htm Edgar Link pending
ea021055601ex31-1_complete.htm Edgar Link pending
ea021055601ex31-2_complete.htm Edgar Link pending
ea021055601ex32-1_complete.htm Edgar Link pending
ex10-2_001.jpg Edgar Link pending
ex10-7_001.jpg Edgar Link pending
ex10-8_001.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cslr-20240630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable